Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Nys

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
The Journal of Medicine and Philosophy|December 16, 2015
Autonomy, Trust, and RespectThomas Nys
The Hastings Center Report|October 13, 2022
On the Authority of Advance Euthanasia Directives for People with Severe Dementia: Reflections on a Dutch CaseHenri Wijsbek, Thomas Nys
Peptides|September 2, 2008
Comparative peptidomics of Caenorhabditis elegans versus C. briggsae by LC-MALDI-TOF MSSteven J Husson, Bart Landuyt, Thomas Nys, et al.
ALTEX|May 3, 2022
Validation of the monocyte activation test with three therapeutic monoclonal antibodiesRuth Daniels, Wim Van der Elst, Nele Dieltjens, et al.
ACS Medicinal Chemistry Letters|November 20, 2020
A Chemical Probe for the Methyl Transferase PRMT5 with a Novel Binding ModeVineet Pande, Weimei Sun, Lijs Beke, et al.
Molecular Cancer Therapeutics|September 29, 2021
Discovery and Pharmacological Characterization of JNJ-64619178, a Novel Small-Molecule Inhibitor of PRMT5 with Potent Antitumor ActivityDirk Brehmer, Lijs Beke, Tongfei Wu, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
The Journal of Medicine and Philosophy|December 16, 2015
Autonomy, Trust, and RespectThomas Nys
The Hastings Center Report|October 13, 2022
On the Authority of Advance Euthanasia Directives for People with Severe Dementia: Reflections on a Dutch CaseHenri Wijsbek, Thomas Nys
Peptides|September 2, 2008
Comparative peptidomics of Caenorhabditis elegans versus C. briggsae by LC-MALDI-TOF MSSteven J Husson, Bart Landuyt, Thomas Nys, et al.
ALTEX|May 3, 2022
Validation of the monocyte activation test with three therapeutic monoclonal antibodiesRuth Daniels, Wim Van der Elst, Nele Dieltjens, et al.
ACS Medicinal Chemistry Letters|November 20, 2020
A Chemical Probe for the Methyl Transferase PRMT5 with a Novel Binding ModeVineet Pande, Weimei Sun, Lijs Beke, et al.
Molecular Cancer Therapeutics|September 29, 2021
Discovery and Pharmacological Characterization of JNJ-64619178, a Novel Small-Molecule Inhibitor of PRMT5 with Potent Antitumor ActivityDirk Brehmer, Lijs Beke, Tongfei Wu, et al.
Pageof 1